ATE145825T1 - Behandlung von erhöhtem blutdruck - Google Patents

Behandlung von erhöhtem blutdruck

Info

Publication number
ATE145825T1
ATE145825T1 AT89912571T AT89912571T ATE145825T1 AT E145825 T1 ATE145825 T1 AT E145825T1 AT 89912571 T AT89912571 T AT 89912571T AT 89912571 T AT89912571 T AT 89912571T AT E145825 T1 ATE145825 T1 AT E145825T1
Authority
AT
Austria
Prior art keywords
blood pressure
treatment
high blood
potassium
preferred
Prior art date
Application number
AT89912571T
Other languages
English (en)
Inventor
R Curtis Morris Jr
Anthony Sebastian
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE145825T1 publication Critical patent/ATE145825T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89912571T 1988-10-21 1989-10-20 Behandlung von erhöhtem blutdruck ATE145825T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21

Publications (1)

Publication Number Publication Date
ATE145825T1 true ATE145825T1 (de) 1996-12-15

Family

ID=22990921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89912571T ATE145825T1 (de) 1988-10-21 1989-10-20 Behandlung von erhöhtem blutdruck

Country Status (13)

Country Link
US (1) US5804204A (de)
EP (3) EP0720855A3 (de)
JP (2) JP2948247B2 (de)
KR (2) KR0178033B1 (de)
AT (1) ATE145825T1 (de)
AU (2) AU635231B2 (de)
CA (2) CA2001123C (de)
DE (2) DE68927519T2 (de)
DK (2) DK175840B1 (de)
HU (2) HU212106B (de)
IL (2) IL92076A (de)
WO (2) WO1990004402A1 (de)
ZA (2) ZA898017B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
EP1350515A1 (de) * 2002-04-05 2003-10-08 Btg International Limited Niedrig-dosierte Kaliumergänzung zur Vorbeugung und Therapie der Hypertonie
WO2003086423A1 (en) * 2002-04-05 2003-10-23 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
MX352695B (es) * 2008-02-06 2017-12-05 Campbell Soup Co Metodos y composiciones para reducir el contenido de sodio en productos alimenticios.
WO2010026136A1 (en) * 2008-09-05 2010-03-11 Unilever Nv Beverages comprising potassium
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
AU4515489A (en) 1990-05-14
DE68927519T2 (de) 1997-04-03
JPH04501419A (ja) 1992-03-12
AU635231B2 (en) 1993-03-18
KR0178033B1 (ko) 1999-03-20
KR900701288A (ko) 1990-12-01
IL92075A0 (en) 1990-07-12
EP0720855A3 (de) 1998-07-08
DE68913311D1 (de) 1994-03-31
AU634988B2 (en) 1993-03-11
DE68927519D1 (de) 1997-01-16
EP0440738B1 (de) 1996-12-04
EP0461111A1 (de) 1991-12-18
HU208923B (en) 1994-02-28
DK72791A (da) 1991-05-14
IL92076A (en) 1995-08-31
CA2001123A1 (en) 1990-04-21
AU4622089A (en) 1990-05-14
DK72691A (da) 1991-04-22
DK175841B1 (da) 2005-03-29
JP2948247B2 (ja) 1999-09-13
CA2001124C (en) 2000-01-18
EP0440738A4 (en) 1991-08-28
EP0440738A1 (de) 1991-08-14
WO1990004403A1 (en) 1990-05-03
DE68913311T2 (de) 1994-05-26
IL92076A0 (en) 1990-07-12
US5804204A (en) 1998-09-08
EP0461111B1 (de) 1994-02-23
HUT63058A (en) 1993-07-28
KR0163583B1 (ko) 1998-12-01
HU212106B (en) 1996-02-28
DK72691D0 (da) 1991-04-19
ZA898017B (en) 1990-12-28
ZA898018B (en) 1990-12-28
KR900701287A (ko) 1990-12-01
DK72791D0 (da) 1991-04-19
HUT57989A (en) 1992-01-28
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
EP0720855A2 (de) 1996-07-10
IL92075A (en) 1995-07-31
JP2843146B2 (ja) 1999-01-06
JPH04501724A (ja) 1992-03-26
CA2001123C (en) 2000-01-18
CA2001124A1 (en) 1990-04-21
DK175840B1 (da) 2005-03-29
WO1990004402A1 (en) 1990-05-03
EP0461111A4 (de) 1991-07-25

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
DK0674511T3 (da) Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE68927519T2 (de) Behandlung von erhöhtem Blutdruck
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
EA200000686A1 (ru) Препараты левозимендана, предназначенные для введения через слизистую оболочку
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
ES2087764T3 (es) Uso del ajo de oso en el tratamiento o prevencion de los trastornos circulatorios.
IL82317A (en) 1,4-dihydropyridine derivatives,processes for their preparation and medicaments containing these compounds
SE7806469L (sv) Antihypertensiva kompositioner
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ES8500055A1 (es) Procedimiento para la obtencion de un medicamento a base de un derivado de pirazolinona.
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
RU94020373A (ru) Способ лечения больных ревматоидным артритом
EA199700034A2 (ru) Способ в.г.соломатова коррекции энергетического состояния живого существа
GEP19981480B (en) Method for Treating Vertebral Column
RU94028152A (ru) Способ лечения острого послеабортного эндометрита
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом
RU93032381A (ru) Способ лечения хронического описторхоза

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee